Hyodo Ryota, Suzuki Kojiro, Ebata Tomoki, Komada Tomohiro, Mori Yoshine, Yokoyama Yukihiro, Igami Tsuyoshi, Sugawara Gen, Naganawa Shinji, Nagino Masato
Department of Radiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
J Hepatobiliary Pancreat Sci. 2015 Apr;22(4):310-5. doi: 10.1002/jhbp.200. Epub 2014 Dec 25.
The aim of the present study was to assess the clinical efficiency of portal vein (PV) stenting when performed with preoperative percutaneous transhepatic portal vein embolization (PTPVE) in patients with severe PV stenosis due to tumor invasion.
Between 2007 and 2013, four consecutive patients (one male, three females; mean age, 52 years; age range, 25-73 years) with perihilar cholangiocarcinoma and PV stenosis underwent PTPVE and PV stenting. Patients were analyzed with regard to the procedure, hypertrophy of the future remnant liver (FRL), and plasma clearance rate of indocyanine green by the FRL (ICGK-F). Further, the %FRL volume increase in PTPVE was compared between the stenting group and the usual PTPVE group who have perihilar cholangiocarcinomas without PV stenosis.
Preoperative PTPVE with PV stenting was successfully performed and portal flow to the FRL improved after stenting in all four patients. The %FRL volume increase was 18-60% (mean, 34%) in the stenting group and was 12-51% (mean, 21%) in the usual PTPVE group. The ICGK-F value after PTPVE exceeded 0.05 in all four patients. All patients achieved R0 resection.
Preoperative PTPVE with PV stenting appears to be feasible in cases of severe PV tumor invasion and stenosis. This procedure may allow a broader indication for surgery.
本研究的目的是评估在因肿瘤侵犯导致门静脉严重狭窄的患者中,术前经皮经肝门静脉栓塞术(PTPVE)联合门静脉(PV)支架置入术的临床疗效。
2007年至2013年期间,4例连续的肝门部胆管癌合并门静脉狭窄患者(1例男性,3例女性;平均年龄52岁;年龄范围25 - 73岁)接受了PTPVE和PV支架置入术。对患者进行了手术过程、未来残余肝(FRL)肥大情况以及FRL对吲哚菁绿的血浆清除率(ICGK - F)的分析。此外,比较了支架置入组与未合并门静脉狭窄的肝门部胆管癌常规PTPVE组PTPVE中FRL体积增加的百分比。
所有4例患者均成功进行了术前PTPVE联合PV支架置入术,支架置入后门静脉向FRL的血流得到改善。支架置入组FRL体积增加百分比为18% - 60%(平均34%),常规PTPVE组为12% - 51%(平均21%)。4例患者PTPVE后的ICGK - F值均超过0.05。所有患者均实现了R0切除。
术前PTPVE联合PV支架置入术在门静脉严重肿瘤侵犯和狭窄的病例中似乎是可行的。该手术可能会扩大手术适应证。